James M. Detore
CIK: 0001623981
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CGON
CG Oncology, Inc.
Officer
Discretionary Trading P&L
Holdings
About DETORE JAMES M.
DETORE JAMES M. (SEC CIK 0001623981) files insider reports with the SEC as Chief Financial Officer of CG Oncology, Inc. (CGON).
Signal8 holds 2 ownership filings by DETORE JAMES M. (1 Form 3, 1 Form 4), filed between Nov 24, 2025 and Apr 16, 2026. Those filings report 1 transaction, the latest on Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DETORE JAMES M.'s filings is in DALLAS, TX.
Recent filings by DETORE JAMES M.
- Apr 15, 2026: Grant or award of CGON derivative securities (Form 4, code A).
Other insiders filing for CG Oncology, Inc. (CGON)
- Kalofonos Isabel, Chief Commercial Officer
- POST LEONARD E, Director
- Mulay James, Director
- Liu Brian Guan-Chyun, Director
- Tong Victor Edward Jr, Director
- Rossi Christina, Director